You are viewing: Canada Endoscopic Submucosal Dissection/ESD Market analysis

The Canada Endoscopic Submucosal Dissection/ESD Market was valued at $4.9 Million in 2025 and projected to reach to $7.3 Million by 2030, representing a compound annual growth rate of 8.3%. Canada's Endoscopic Submucosal Dissection market is positioned for steady growth through 2030, supported by the country's robust healthcare infrastructure and increasing adoption of minimally invasive techniques.

Canada Endoscopic Submucosal Dissection/ESD Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Endoscopic Submucosal Dissection/ESD Market Trends and Insights

  • This represents a compound annual growth rate (CAGR) of 8.3%, reflecting increasing adoption of minimally invasive endoscopic procedures across Canadian healthcare institutions.
  • Canada's advanced healthcare infrastructure and rising prevalence of gastrointestinal malignancies are driving demand for ESD technologies and training. The Canadian ESD market benefits from strong healthcare spending, regulatory support, and growing physician expertise in advanced endoscopic techniques.
  • Canada's aging population and improved early detection of precancerous lesions are key factors accelerating market expansion between 2025 and 2030.
  • Investment in endoscopy centers and hospital infrastructure modernization further supports market growth throughout the forecast period..

Key Market Statistics

  • CAGR (2025-2030) 8.3% CAGR
  • Market Size, 2025 ~USD 4.9 Million
  • Forecast, 2030 ~USD 7.3 Million
  • Country Canada

Canada Endoscopic Submucosal Dissection/ESD Market Overview

Market Valuation Growth :

Canada's ESD market is valued at $4.9 million in 2025, with projections reaching $7.3 million by 2030, demonstrating robust expansion in minimally invasive endoscopic procedures across the country.

Steady CAGR Performance :

The Canadian market exhibits a CAGR of 8.3% from 2025-2030, slightly below the global average of 8.4%, indicating consistent adoption rates aligned with international trends in advanced endoscopic technologies.

Healthcare Infrastructure Advantage :

Canada's advanced healthcare system and well-established medical institutions provide a strong foundation for ESD adoption, with increasing integration of minimally invasive procedures in gastroenterology departments nationwide.

Rising Procedural Adoption :

Growing awareness among Canadian healthcare providers and patients regarding benefits of ESD over traditional surgical interventions is driving increased procedure volumes and market penetration across provinces.

Canada Endoscopic Submucosal Dissection/ESD Market Dynamics

  • Provincial healthcare systems are progressively integrating ESD capabilities into gastroenterology centers, driven by clinical evidence supporting superior patient outcomes and reduced recovery times compared to conventional surgery.
  • The 8.3% CAGR reflects growing procedural volumes and expanding reimbursement coverage across Canadian provinces.
  • Key drivers include aging demographics, rising gastrointestinal cancer prevalence, and healthcare provider investment in advanced endoscopic equipment and training programs..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Canada's ESD market is valued at $4.9 million in 2025 and expected to reach $7.3 million by 2030, growing at 8.3% CAGR.
    • Canada's advanced healthcare system and aging demographic are primary drivers of ESD adoption and market expansion.
    • Increased investment in endoscopy infrastructure and physician training programs across Canada supports market growth.
    • Canada's regulatory environment and healthcare reimbursement policies favor adoption of minimally invasive endoscopic procedures.

    Endoscopic Submucosal Dissection/ESD Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment KNIVES (Product)
    Forecast Period 2025–2030
    Growth Rate CAGR of 8.4% from 2025 to 2030
    Largest Segment GASTROSCOPES & COLONOSCOPES (Product)
    Market Size Base Year (Billions) ~USD 0.5 (2025)
    Revenue Forecast (Billions) ~USD 0.75 (2030)
    Segments Covered Product, Indication, End User

    Canada Endoscopic Submucosal Dissection/ESD Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Product

    • Gastroscopes & Colonoscopes
    • Grasp/Clips
    • Graspers/Clips
    • Injection Agents
    • Knives
    • Other Products
    • Tissue Retractors

    By Indication

    • Colon Cancer
    • Esophageal Cancer
    • Stomach Cancer

    By End User

    • Ambulatory Surgical Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGICAL CENTERS1.531.631.781.912.072.252.432.638.1
    HOSPITALS5.535.96.4977.628.2999.788.6
    OTHER END USERS0.240.250.270.290.310.330.350.386.8
    SPECIALTY CLINICS1.851.962.142.292.482.682.893.127.8
    TOTAL9.159.7410.6811.4912.4813.5514.6715.918.3

    Target Audience

    • Medical Device Manufacturers : Manufacturers of endoscopic equipment and ESD devices need Canada-specific market data to develop localized product strategies, identify distribution partnerships, and optimize market entry across provinces.
    • Healthcare System Administrators : Hospital networks and provincial health authorities require market insights to justify ESD program investments, benchmark adoption rates against peer institutions, and plan capital equipment budgets.
    • Gastroenterology Specialists : Canadian gastroenterologists and endoscopy center directors need market intelligence to understand procedural demand trends, training opportunities, and competitive positioning within their regions.
    • Healthcare Consultants & Investors : Management consulting firms and healthcare investors analyzing Canadian market opportunities require detailed ESD market data to assess growth potential, identify acquisition targets, and guide investment decisions.
    • Regulatory & Policy Bodies : Health Canada officials and provincial health policy makers need market research to inform reimbursement policies, clinical guidelines, and healthcare resource allocation for endoscopic procedures.

    Key Companies in the Canada Endoscopic Submucosal Dissection/ESD Market

    CompanyHQOwnershipStrongest segments
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Urology,Respiratory,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative medicine, cosmetics/supplements),Electronics (display/touch, semiconductor and image sensor materials, storage/archiving, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications, inkjet heads),
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, peripheral interventions, oncology),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    SUMITOMO BAKELITE CO., LTD.JapanPublic CompanySemiconductor encapsulation and substrate materials,Phenolic molding compounds and industrial resins,Copper-clad laminates (phenolic and epoxy),
    CREO MEDICAL GROUP PLCUnited KingdomPublic CompanyCROMA platform and capital equipment,Speedboat Inject and multimodal endoscopic instruments,MicroBlate Fine and MicroBlate Flex ablation devices,
    HOYA CORPORATIONJapanPublic CompanyEyeglasses and ophthalmic lenses,Contact lenses and Eyecity retail,Intraocular lenses and surgical ophthalmology,
    CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic & Sports Medicine (BioBrace, Y-Knot, TruShot, Hall power tools),General Surgery (AirSeal insufflation, Buffalo Filter smoke, endomechanical),Endoscopic Technologies (GI therapeutic and diagnostic),
    STERISIrelandPublic CompanyHealthcare sterilization and washer-disinfectors,Endoscope reprocessing systems and consumables,Operating room equipment and integration,

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer with significant operations in medical devices and imaging technology.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees. It is a global leader in medical technology, services, and solutions.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japanese public company established in 1934 with 73,526 employees. The company operates across imaging, information, and document solutions, as well as healthcare and materials sectors.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. It specializes in the development and manufacture of medical devices and technologies.

    SUMITOMO BAKELITE CO., LTD.

    Sumitomo Bakelite Co., Ltd. is a Japanese public company founded in 1932 with 7,524 employees. The company manufactures advanced materials and components for various industrial applications.

    CREO MEDICAL GROUP PLC

    Creo Medical Group PLC is a United Kingdom-based public company founded in 2003 with 104 employees. The company develops and commercializes medical devices and technologies.

    HOYA CORPORATION

    Hoya Corporation is a Japanese public company established in 1941 with 37,752 employees. The company manufactures optical products, medical devices, and precision equipment.

    CONMED CORPORATION

    CONMED Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company designs, manufactures, and sells medical devices and equipment for surgical and patient monitoring applications.

    STERIS

    STERIS is a public company headquartered in Ireland, founded in 1985. The company provides sterilization and contamination control products and services for healthcare and industrial markets.

    Reasons to Buy this Report

    • Provincial Market Segmentation : Gain detailed insights into ESD adoption rates across Canadian provinces, identifying high-growth regions and healthcare systems with greatest procedural demand and investment capacity.
    • Reimbursement & Coverage Analysis : Understand provincial healthcare coverage policies, reimbursement structures, and funding mechanisms that influence ESD procedure accessibility and market expansion across Canada's fragmented healthcare system.
    • Competitive Landscape Intelligence : Identify key medical device manufacturers, endoscopy equipment suppliers, and service providers operating in Canada, including market share distribution and strategic positioning within the country.
    • Clinical Adoption Trends : Access data on ESD procedure volumes, hospital adoption rates, and training program expansion across Canadian gastroenterology centers, revealing market maturity and growth opportunities.
    • Regulatory & Market Entry Strategy : Navigate Health Canada regulations, provincial approval processes, and market entry requirements specific to ESD devices and services, enabling informed commercialization strategies.

    Frequently asked questions

    What is the current size of Canada's ESD market?

    Canada's Endoscopic Submucosal Dissection market was valued at $4.9 million in 2025.

    What is the projected market size for Canada's ESD market by 2030?

    Canada's ESD market is projected to reach $7.3 million by 2030, representing 48.98% growth over the forecast period.

    What is the CAGR for Canada's ESD market?

    Canada's ESD market is expected to grow at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2030.

    What factors are driving growth in Canada's ESD market?

    Key drivers include Canada's aging population, rising gastrointestinal malignancy prevalence, advanced healthcare infrastructure, and increased physician training in endoscopic techniques.

    How does Canada's ESD market compare to global trends?

    Canada's 8.3% CAGR is slightly below the global average of 8.4%, reflecting mature healthcare adoption patterns in Canada's developed market.

    RESEARCH METHODOLOGY

    The study focused on estimating the current size of the endoscopic submucosal dissection (ESD) market. We conducted thorough secondary research to gather information about the market. The next step involved validating our findings, assumptions, and estimates through primary research by consulting industry experts throughout the value chain. We used various approaches, including top-down and bottom-up methods, to calculate the total market size. Subsequently, we applied market breakdown and data triangulation techniques to estimate the sizes of different segments and subsegments within the ESD market.

    Secondary Research

    This research study heavily utilized secondary sources, including directories and databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and company documents. The purpose of the secondary research was to identify and gather information for a comprehensive, technical, market-oriented, and commercial analysis of the endoscopic submucosal dissection (ESD) market. It also aimed to collect vital information about leading industry players, market classification, and segmentation according to industry trends, down to the most granular levels, as well as geographic markets and key developments related to the market. Additionally, a database of key industry leaders was created based on the findings from the secondary research.

    Primary Research

    During the primary research process, a variety of supply-side and demand-side sources were interviewed to gather both qualitative and quantitative information for this report. On the supply side, primary sources included industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, engineers, and other key executives from various companies and organizations operating in the ESD market. On the demand side, primary sources encompassed hospitals, clinics, researchers, lab technicians, purchasing managers, and stakeholders from corporate and government bodies.

    Breakdown of Primary Interviews

    Endoscopic Submucosal Dissection Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ESD market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Endoscopic Submucosal Dissection Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ESD. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

    Stakeholders

    • Manufacturers of endoscopes and related devices
    • Suppliers and distributors of endoscopy devices
    • Hospitals, diagnostic centers, and medical colleges
    • Independent surgeons and private offices of physicians
    • Ambulatory surgery centers (ASCs)
    • Teaching hospitals and academic medical centers
    • Government bodies/municipal corporations
    • Business research and consulting service providers
    • Venture capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the endoscopic submucosal dissection market by product, indication, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall endoscopic submucosal dissection market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the endoscopic submucosal dissection market in six regions: North America (US and Canada), Europe (Germany, the UK, France, Spain, Italy, and the Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), the Middle East & Africa, and the GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full Endoscopic Submucosal Dissection/ESD Market Report

    Full forecast, segment splits, and company analysis for all Endoscopic Submucosal Dissection/ESD Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status